Introduction: The Critical Intersection of Crimping and Seal Integrity
The vial sealing process is one of the most critical process steps during fill-and-finish operations, as it defines the seal quality of the final product. The most commonly used container closure system (CCS) configuration for parenteral drug products is the glass vial, sealed with a rubber stopper and an aluminum crimp cap. In combination with an adequately designed and controlled aseptic fill/finish process, a well-designed and characterized capping process is indispensable to ensure product quality and integrity.
According to EU GMP Annex 1, an aseptically filled vial is not regarded as fully closed until the aluminum cap has been crimped onto the stoppered vial. Uncapped vials carry the risk of stopper dislodgement or poor sealing, so after stoppering, strict storage conditions must be defined and crimping completed as soon as possible. Crimping—the process of mechanically deforming the aluminum skirt under the vial neck finish to clamp the stopper flange—maintains stopper compression over time. This mechanical lock is what ensures long-term product integrity and sterility.
At Vialab Pharmaceutical Packaging Co., Ltd. , we specialize in the design and manufacture of high-quality drug delivery and packaging components, including aluminum caps and aluminum-plastic combination caps. Our products are engineered to meet strict pharmaceutical standards, with advanced production lines and cleanroom facilities ensuring consistent quality, integrity, and compliance for global healthcare partners.
This article provides a comprehensive examination of crimping parameters and seal integrity testing—exploring the critical process parameters, measurement techniques, regulatory standards, and best practices that ensure container closure integrity throughout the product lifecycle.
1. Understanding the Crimping Process
1.1 Definition and Mechanism
Crimping is defined as the process of fixing an aluminum or aluminum-plastic cap onto a rubber stopper and sealing the vial opening. The process involves the application of both vertical and horizontal compressive forces during the aluminum cap application. These forces deform the aluminum skirt, creating a mechanical lock that secures the stopper in its compressed state against the vial’s sealing surfaces.
The seal itself is comprised of three major parts: the glass vial, a rubber stopper, and an aluminum cap that secures the rubber stopper in the vial. The aluminum cap must be crimped onto the stoppered vial with a compressive force that will ensure sufficient mating of the glass and rubber surfaces.
1.2 Critical Crimping Parameters
Different critical capping process parameters can affect rubber stopper defects, rubber stopper compression, container closure integrity, and crimp cap quality. The key parameters include:
Crimp Pressure: The force applied during the crimping operation. Validation of sealing processes requires defining critical process parameters such as crimp pressure for vial capping. Insufficient pressure results in loose caps and potential seal failure; excessive pressure can cause stress cracks in the vial neck area.
Crimp Diameter: The final diameter of the crimped cap, which must fall within specified tolerances to ensure proper sealing.
Crimp Depth/Height: The vertical position of the crimped cap relative to the vial neck finish.
Crimp Speed: The rate at which the crimping operation is performed, which can affect the deformation characteristics of both the aluminum and the rubber stopper.
Tooling Condition: The condition of the crimping dies and chucks, including wear and alignment, directly impacts seal quality.
1.3 The Stopper’s Dual Sealing Surfaces
The stopper in a vial-based container closure system provides two distinct sealing surfaces:
The Valve Seal: The primary seal formed between the stopper’s plug portion and the inner wall of the vial neck. This seal is critical for maintaining container closure integrity.
The Land Seal: The secondary seal formed between the stopper’s flange (underside) and the top surface (land) of the vial finish. The land seal is typically considered the primary final seal for maintenance of container closure integrity.
Research has demonstrated that vials with only the valve seal (and no land seal) can still pass leakage testing for certain CCS configurations, while vials with only the land seal fail CCI at low residual seal force values. This underscores the importance of understanding both sealing mechanisms when establishing crimping parameters.
2. Residual Seal Force: The Quantifiable Measure of Seal Quality
2.1 Definition and Significance
Residual Seal Force (RSF) is defined as the force a closure exerts against the vial after the initial seal is made. The initial force with which the closure compresses the vial is a function of the vertical and horizontal crimping forces applied during the aluminum cap application.
However, due to the viscoelastic relaxation behavior of rubber, the force of the closure pressing against the vials decays as a function of time, elastomer composition, and as a result of various processing procedures. This makes RSF measurement essential for understanding the long-term sealing performance of the container closure system.
RSF is considered the sole quantifiable attribute for measuring seal “goodness” and potentially enables nonsubjective, consistent setting of cappers across manufacturing sites. It is a seal quality test that provides quantitative data to enable consistent, predictable capping compression.
2.2 RSF Measurement Methodology
The measurement of RSF requires a specialized testing apparatus. The vial specimen is positioned between platens, and compressive force is applied. The force required to overcome the residual seal force is the point at which the lower lip of the aluminum cap “breaks away” and begins to move in the direction of compressive load.
A method for performing such a test was described by Morton and Lordi in a research article titled “Residual Seal Force Measurement of Parenteral Vials, I. Methodology” from the Journal of Parenteral Science and Technology (Jan/Feb, 1988). Modern implementations typically use electromechanical test frames with appropriate load cells.
2.3 RSF and Container Closure Integrity Correlation
The relationship between RSF and Container Closure Integrity (CCI) has been extensively studied. One study correlated RSF with CCI via helium leakage testing, although CCI was not found to be sensitive to RSF across all ranges—CCI was maintained even for loosely capped vials with no measurable RSF.
Despite the inherent variability of RSF, studies show that it is a feasible parameter for capping process quantification and demonstrates the potential of RSF measurement in capper setup. A controlled capping process with a defined target residual seal force range leads to a tight crimp cap on a sealed container closure system and can ensure product quality.
2.4 Sources of RSF Variability
All RSF values exhibit significant variability. Research has evaluated four potential sources of variability:
- The Capper: Equipment differences between machines
- The RSF Tester: Instrumentation variability
- Time-Dependent Nature: Relaxation of the elastomeric stopper over time
- The Components: Dimensional tolerances of packaging components
Studies have determined that the capper, the tester, and the time-dependent nature are not the main sources of variability. Rather, dimensional tolerances of the packaging components were identified as the root cause for the CCS configurations tested. This finding highlights the importance of tight dimensional control for all components—vials, stoppers, and caps.
3. Crimping Parameter Optimization: The Capping Study Approach
3.1 The Capping Study Methodology
A specific, upstream and preventive CCI program gaining popularity as part of a full lifecycle approach to CCI verification is that of a “Capping Study”—a program in which optimal sealing parameters are determined through correlation with low leakage rates.
In such programs, there are typically a range of sample sets assembled at capping parameters from very low (aluminum crimp seal barely applied) to very high (possibly yielding stress cracks in the vial neck area). These samples are subsequently assessed for:
- Percentage compression of the stopper
- Residual Seal Force (RSF)—an indirect measure of the amount of force the stopper is applying to the land-seal of the vial
- Leak testing incorporating USP <1207> methodologies
3.2 Correlating Parameters with Leak Performance
As each set of samples undergo leak testing, differences in leak performance between the sets can be identified. An ideal set of capping parameters that correlates to consistently low leak rates can be determined. Additionally, an ideal residual seal force range can be identified.
Furthermore, by incorporating component dimensional variation into the study design, component dimensional specifications can be established or verified, ensuring integrity performance across the possible matrix of package component dimensional stack-up, overlap, and interference fit.
The correlations between capping parameters, RSF, dimensions, and leakage can be immensely valuable. This work can be performed at lab-scale for development purposes, helping to inform final settings for a manufacturing setting.
3.3 Establishing Lower RSF Limits
A test methodology based on a statistical approach has been proposed for establishing permissible lower residual force limits that would provide a high degree of confidence to the capper process. This statistical approach allows the relationship between RSF’s low limit and an allowable failing rate to be established.
The establishment of a low RSF limit that is safe—even when the valve seal is defective—provides a robust quality assurance framework. Simplified statistical analysis of commercial capping data, with the input of sample size, allows this relationship to be quantified.
4. Seal Integrity Testing: Methodologies and Standards
4.1 Package Seal Quality Tests vs. Leak Tests
USP <1207> distinguishes between two categories of tests for evaluating container closure systems:
Package Seal Quality Tests (USP <1207.3>): These are checks used to characterize and monitor the quality and consistency of a parameter related to the package seal, providing some assurance of the package’s ability to remain integral. These methods are not leak tests but provide additional data regarding package seal characteristics that may affect package integrity and leakage. Examples include RSF measurement, torque testing, and visual inspection.
Package Integrity Leak Tests (USP <1207.2>): These are tests that directly measure leakage from the container closure system. USP <1207> provides guidance on the integrity assurance of nonporous packages intended to hold sterile pharmaceutical products, including background instruction on leaks, leakage rate, and package sealing/closure mechanisms.
4.2 Deterministic Leak Test Methods
USP <1207> states a preference for deterministic tests on the basis that they are non-invasive, produce repeatable and predictable results, and are suited to 100% testing. A deterministic leak test method is one in which the leakage event being detected or measured is based on phenomena that follow a predictable chain of events.
Common deterministic leak methods noted in USP <1207> include:
Vacuum Decay Testing: A non-destructive and deterministic leak test method to identify leaks in pharmaceutical containers. The container is placed in a tightly fitted chamber which is evacuated to a predetermined level of vacuum. After reaching the pre-set vacuum, the system monitors for pressure changes that indicate the presence of leaks. This method is compliant with ASTM F2338, which is recognized by the FDA as a consensus standard for package integrity testing.
Helium Leak Detection: A highly sensitive container closure integrity method that uses helium gas as a tracer to detect defects in pharmaceutical packaging systems. Helium mass spectrometry leak detection (vacuum mode) can effectively test the container-closure integrity of vials. The absolute leak rate is determined using vials sealed in a tracer (helium) environment with butyl rubber stoppers and crimps. Acceptance criteria are typically established at levels such as 1×10⁻⁶ mbar·L·s⁻¹.
High Voltage Leak Detection (HVLD): A deterministic test method referenced in USP <1207> guidance for container closure integrity testing.
Laser Diffraction: Another deterministic method noted in USP <1207>.
4.3 The Maximum Allowable Leakage Limit (MALL)
A critical concept in USP <1207> is the Maximum Allowable Leakage Limit (MALL)—the greatest leakage rate (or leak size) tolerable for a given product-package that poses no risk to product safety and no or inconsequential impact on product quality.
A container is considered to have integrity if it allows no leakage greater than the product-package maximum allowable leakage limit. For sterile pharmaceutical dosage forms, the MALL ensures the content’s sterility, preserves product contents, and prevents entry by detrimental gases or other substances.
4.4 Regulatory Framework
Container Closure Integrity Testing is a GMP-mandated requirement and a critical quality attribute for pharmaceutical products. Regulatory authorities like the FDA, EMA, and WHO emphasize CCI as an essential requirement for GMP compliance and product approval.
FDA guidance on container and closure system integrity testing focuses on the use of CCI testing in lieu of sterility testing as part of the stability protocol for sterile products. A validated container and closure system integrity test may replace sterility testing under certain conditions.
The FDA expects manufacturers to demonstrate that container closure systems consistently prevent contamination. This expectation applies across development, clinical trials, validation, commercial manufacturing, and distribution. Deterministic CCIT is preferred by all regulatory bodies because it replaces assumption-based testing with measurable evidence.
A significant regulatory change is coming with USP <382>: Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems, effective December 2025. Expanding on USP <1207>, this new guidance requires that integrity testing be performed.
5. ISO 8872:2022 and Crimping Requirements
ISO 8872:2022—the consolidated standard for aluminum caps and aluminum-plastic combination caps—specifies general requirements and test methods for caps intended for use on infusion bottles and/or injection vials.
5.1 Requirements for the Aluminum Component
The standard specifies requirements for the aluminum component including:
- Mechanical characteristics: Tensile strength and elongation
- Chemical composition: Material specifications
- Dimensions: Critical dimensional tolerances
- Contamination: Freedom from contaminants
- Earing: The waviness of the加工 edge, typically not exceeding 3%
- Other defects: Surface imperfections and anomalies
5.2 Functional Requirements
Section 4.4 of ISO 8872:2022 addresses the functional requirements of aluminum and aluminum-plastic caps:
- Opening and tear-off forces for aluminum caps
- Joining of aluminum and plastic component: For combination caps, the bond must withstand normal handling without delamination
- Opening and tear-off forces for aluminum/plastic caps
- Mechanical requirements after sterilization
5.3 Test Methods
The standard specifies test methods for:
- Mechanical characteristics (per ISO 6892-1)
- Chemical composition
- Dimensions
- Earing
- Opening and tear-off forces (Annex B, normative)
- Stability of coating after sterilization
- Premature opening and deformation after sterilization
5.4 The Crimping Definition in ISO 8872:2022
ISO 8872:2022 formally defines crimping as “the process of fixing an aluminum or aluminum-plastic cap onto a rubber stopper and sealing the vial opening”. This definition underscores that crimping is not merely a mechanical assembly step but a critical sealing operation that directly impacts product quality.
6. Correlative Testing: The Interplay of Parameters
6.1 RSF, Torque Moment, and Flip-Off Removal Force
A comprehensive study investigated the correlation between Residual Seal Force, torque moment required to turn the crimp cap, and the force required to remove the flip-off button.
The torque moment was found to be influenced by several parameters, including:
- Diameter of the vial head
- Type of rubber stopper (serum or lyophilized)
- Type of crimp cap
The capping process had no influence on measured flip-off removal forces; however, it was possible to detect partially crimped vials through this testing. A sufficiently high force to remove the flip-off button prior to usage is required to ensure quality of the drug product unit during storage, transportation, and until opening and use.
6.2 Flip-Off Removal Force as a Process Indicator
Testing the flip-off removal force is a good indicator of whether the capping machine has applied excessive force and possibly damaged the cap’s retaining lugs, or has caused the lyophilization stopper to expand and pop off the vial cap. This makes flip-off removal force testing a valuable in-process control measure.
6.3 Torque Moment Testing
Torque moment testing—measuring the force required to turn the crimp cap—provides another quantitative measure of seal quality. This test can detect issues with crimp cap tightness that might not be apparent through visual inspection alone.
7. Implementation Best Practices
7.1 Establishing Crimping Parameters
When establishing crimping parameters for a new product, manufacturers should:
- Conduct a capping study across a range of crimping parameters from very low to very high
- Measure RSF for each set of samples
- Perform leak testing using deterministic methods per USP <1207>
- Identify the parameter set that correlates with consistently low leak rates
- Establish an ideal RSF range
- Verify component dimensional specifications across the matrix of possible dimensional stack-ups
7.2 In-Process Control
Manufacturing capping settings should be tailored to yield package RSF data in line with laboratory results. Samples can be pulled from the line at each site and routinely checked by RSF as an in-process control. If the samples pulled off the line exhibit RSF values within a range that correlates to reduced risk of leakage and is consistent with historical data, capping processes are likely under control.
Although this does not guarantee package integrity, it provides an added layer of assurance and can be referred to as an ongoing seal quality test.
7.3 Technology Considerations
Modern capping equipment, such as the Genesis Integra capper, can accommodate a range of package sizes and forces. When selecting capping equipment, consider:
- Capping technique: The most common capping equipment with a rotating capping plate produces the lowest amount of particles
- Force control: Ability to precisely control vertical and horizontal crimping forces
- Monitoring capability: Integration with RSF measurement and data collection systems
- Tooling maintenance: Regular inspection and replacement of crimping dies and chucks
8. Vialab’s Commitment to Crimping Excellence
At Vialab Pharmaceutical Packaging Co., Ltd. , we understand that the crimping process is the final, critical step in ensuring container closure integrity. Our aluminum caps and aluminum-plastic combination caps are manufactured to meet the stringent requirements of ISO 8872:2022, with:
- Pharmaceutical-grade aluminum alloys meeting specified mechanical properties (100–180 N/mm² tensile strength, not less than 2.0% elongation)
- Precision manufacturing ensuring dimensional accuracy
- Cleanroom production ensuring product cleanliness
- Comprehensive quality control at every stage
- Compatibility with all common capping equipment and sterilization methods
Whether you require standard 13 mm or 20 mm aluminum caps, aluminum-plastic combination caps with flip-off or tear-off designs, or customized solutions for specialized applications, Vialab delivers precision, safety, and reliability in every component.
Conclusion
Crimping parameters and seal integrity testing represent a critical intersection of process control, quality assurance, and patient safety in pharmaceutical packaging. The crimping process—the mechanical deformation of the aluminum cap to secure the stopper—is the final step that transforms a stoppered vial into a fully closed container closure system.
Residual Seal Force has emerged as the sole quantifiable attribute for measuring seal “goodness,” enabling nonsubjective, consistent setting of cappers across manufacturing sites. Through capping studies that correlate crimping parameters with RSF and leak testing results, manufacturers can establish optimal parameter ranges that ensure container closure integrity throughout the product lifecycle.
The regulatory framework—including ISO 8872:2022, USP <1207>, and FDA guidance—provides clear expectations for crimping process validation and seal integrity testing. Deterministic leak test methods such as vacuum decay and helium leak detection offer the repeatable, predictable results that regulatory authorities prefer.
As the pharmaceutical industry continues to advance, the integration of capping studies, RSF measurement, and CCI testing into product development and commercial manufacturing will become increasingly essential. At Vialab, we remain committed to supporting our partners with high-quality components and the technical expertise needed to achieve robust, reliable seals that protect patient safety.
References
- ISO 8872:2022 – Aluminium caps and aluminium/plastic caps for infusion bottles and injection vials — General requirements and test methods
- USP <1207> – Package Integrity Evaluation — Sterile Products
- USP <1207.3> – Package Seal Quality Test Technologies
- EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
- Mathaes R, et al. The Pharmaceutical Capping Process—Correlation between Residual Seal Force, Torque Moment, and Flip-off Removal Force. PDA J Pharm Sci Technol. 2016 May-Jun;70(3):218-29
- Ovadia R, et al. Quantifying the Vial Capping Process: Residual Seal Force and Container Closure Integrity. PDA J Pharm Sci Technol. 2019 Jan-Feb;73(1):2-15
- Instron. Residual Seal Force Measurement of Parenteral Vials
- CS Analytical. Capping Optimization and Assembly Validation
- ScienceDirect. The pharmaceutical vial capping process: Container closure systems, capping equipment, regulatory framework, and seal quality tests
- ASTM F2338 – Standard Test Method for Nondestructive Detection of Leaks in Packages by Vacuum Decay Method
This article is provided for informational purposes only and does not constitute regulatory advice. Manufacturers should consult with qualified experts and regulatory authorities for specific product validation and compliance.